Accessibility Menu
ProShares Trust - ProShares Ultra Nasdaq Biotechnology logo

ProShares Trust - ProShares Ultra Nasdaq Biotechnology(NASDAQ) BIB

Current Price$98.51
Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2010)+1,241%
5 Year+1%
1 Year+87%
1 Month+6%
ProShares Trust - ProShares Ultra Nasdaq Biotechnology last closing stock price
MetricPriceDate
Last closeUSD 97.882026-07-24
ProShares Trust - ProShares Ultra Nasdaq Biotechnology stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-2.2%USD 100.082026-07-17
1 month+6.04%USD 92.312026-06-24
3 month+18.35%USD 82.712026-04-24
Year to date+22.7%USD 79.772025-12-31
1 year+86.91%USD 52.372025-07-24
3 year+92.22%USD 50.922023-07-25
5 year+0.92%USD 96.992021-07-23
Since inception+1,241.37%USD 7.302010-04-08

ProShares Trust - ProShares Ultra Nasdaq Biotechnology Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.32

Beta (Volatility)

1.64 (High)

Price

$98.51

Volume

3,484

Open

$100.00

Previous Close

$97.88

Daily Range

$97.68 - $100.00

52-Week Range

$49.24 - $110.25

Estimated Earnings Date

N/A

BIB News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About ProShares Trust - ProShares Ultra Nasdaq Biotechnology

ProShares Ultra Nasdaq Biotechnology is an exchange-traded fund that aims to deliver twice the daily performance of the Nasdaq Biotechnology Index. The fund primarily invests in stocks of companies within the biotechnology and pharmaceutical sectors, utilizing derivatives to achieve its investment objectives.

Products and Services
  • Exchange-traded fund focused on biotechnology and pharmaceuticals
  • Utilizes derivatives like swaps for investment strategies
  • Targets growth and value stocks across various market capitalizations
Growth Outlook
  • Recent stock price reached a year high of $99.29
  • Market capitalization stands at approximately $85.5 million
  • Dividend yield of 0.50% reflects steady income potential
Financial Highlights
  • Recent trading volume averaged 26,178 shares
  • Stock price fluctuated between $45.46 and $99.29 over the year
  • Quarterly dividend paid was $0.4929 per share
ProShares Ultra Nasdaq Biotechnology offers a unique investment opportunity for those interested in the biotechnology sector. The fund's strategy of leveraging derivatives allows for amplified exposure to the performance of the Nasdaq Biotechnology Index, which can be appealing in a rapidly evolving market. The recent stock price performance indicates strong investor interest, while the dividend yield provides a potential income stream. With a focus on both growth and value stocks, the fund is positioned to capitalize on advancements in healthcare and biotechnology.
AI Generated • Jun 28, 2026

Industry

Capital Markets

Sector

Financials

Headquarters

Bethesda, MD 20814, US

BIB Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.33%

Payout Ratio

N/A

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

0

Volume

3.48K

Avg. Volume

10.81K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

ProShares Trust - ProShares Ultra Nasdaq Biotechnology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,411.98+0.00%
^DJIDJI
$51,947.25+0.00%
^IXICNASDAQ
$24,975.82-0.01%
BTCBitcoin
$64,301.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
SOFISoFi Technologies
$16.46-0.01%

Questions About BIB

What is the current price of ProShares Trust - ProShares Ultra Nasdaq Biotechnology?

ProShares Trust - ProShares Ultra Nasdaq Biotechnology is trading at $97.88 per share.

What is the 52-week range for ProShares Trust - ProShares Ultra Nasdaq Biotechnology?

Over the past 52 weeks, ProShares Trust - ProShares Ultra Nasdaq Biotechnology has traded between $49.24 and $110.25.

How much debt does ProShares Trust - ProShares Ultra Nasdaq Biotechnology have?

ProShares Trust - ProShares Ultra Nasdaq Biotechnology total debt is unavailable.

How much cash does ProShares Trust - ProShares Ultra Nasdaq Biotechnology have on hand?

ProShares Trust - ProShares Ultra Nasdaq Biotechnology does not have cash on hand data available.

What is ProShares Trust - ProShares Ultra Nasdaq Biotechnology’s dividend yield?

ProShares Trust - ProShares Ultra Nasdaq Biotechnology currently has a dividend yield of 0.33%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services